General Information of the Compound
| Compound ID |
CP0468117
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
AC1M3OE0
AKOS000813205
BDBM50097440
CHEMBL165783
F3394-1092
HMS3451M02
MCULE-2440953367
MolPort-000-646-915
N-(3-Phenyl-1,2,4-thiadiazole-5-yl)benzamide
N-(3-Phenyl-[1,2,4]thiadiazol-5-yl)-benzamide
N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide
ST45223360
STL202734
UPCMLD0ENAT5889812:001
VU0618368-1
ZINC2889428
phenyl-N-(3-phenyl(1,2,4-thiadiazol-5-yl))carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H11N3OS
|
||||||||||||||||||
| Molecular Weight |
281.34
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1nc(ns1)-c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H11N3OS/c19-14(12-9-5-2-6-10-12)17-15-16-13(18-20-15)11-7-3-1-4-8-11/h1-10H,(H,16,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AYSLYXJUYHXKHV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound